LMO3 antibody (C-Term)
Quick Overview for LMO3 antibody (C-Term) (ABIN7185097)
Target
See all LMO3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- LMO3 Antibody
-
Cross-Reactivity
- Monkey, Mouse, Rat
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human LMO3.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LMO3 (LIM Domain Only 3 (Rhombotin-Like 2) (LMO3))
-
Alternative Name
- LMO3
-
Background
- DAT 1 antibody, DAT1 antibody, LIM domain only 3 (rhombotin like 2) antibody, LIM domain only protein 3 antibody, LMO 3 antibody, LMO-3 antibody, lmo3 antibody, LMO3_HUMAN antibody, MGC26081 antibody, Neuronal specific transcription factor DAT1 antibody, Neuronal-specific transcription factor DAT1 antibody, RBTN 3 antibody, RBTN3 antibody, RBTNL 2 antibody, RBTNL2 antibody, RHOM 3 antibody, RHOM3 antibody, Rhombotin 3 antibody, Rhombotin like 2 antibody, Rhombotin-3 antibody, Rhombotin3 antibody
-
UniProt
- Q8TAP4
-
Pathways
- Dopaminergic Neurogenesis
Target
-